![](/themes/TruffleTheme/static/img/building-bg/building-bg_ykki6o_c_scale,w_2076.jpg)
![abivaxlogo.jpeg](/assets/f1500x900-q85-p1/01e18948/abivaxlogo.jpeg)
Abivax provides business update on most recent achievements and announces positive results of annual ordinary and extraordinary general meeting
miR-AGE study has been approved by French and German regulators, and most recently by the British and Italian regulatory authorities